All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

259

Reset

259 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • Meiji Seika Pharma Co., Ltd. · Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia

  • Meiji Seika Pharma Co., Ltd. · Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia

  • DTGPhase 32 trials

    Jiangsu Aidea Pharmaceutical Group Co., Ltd. · Infection, Human Immunodeficiency Virus, HIV Infections

  • FosmanogepixPhase 32 trials

    Basilea Pharmaceutica · Candidemia, Candidiasis, Invasive, Invasive Mold Infections

  • FTCPhase 32 trials

    Jiangsu Aidea Pharmaceutical Group Co., Ltd. · Infection, Human Immunodeficiency Virus

  • GP681Phase 32 trials

    Jiangxi Qingfeng Pharmaceutical Co. Ltd. · Influenza, Human, Influenza

  • GP681 SimulantPhase 32 trials

    Jiangxi Qingfeng Pharmaceutical Co. Ltd. · Influenza, Human, Influenza

  • HepalatideL47, HLTPhase 32 trials

    Shanghai HEP Pharmaceutical Co., Ltd. · Hepatitis D, Chronic, Hepatitis D

  • HRS-5635Phase 32 trials

    Fujian Shengdi Pharmaceutical Co., Ltd. · Chronic Hepatitis B, Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients With Chronic Hepatitis B

  • HRS-8427Phase 32 trials

    Jiangsu HengRui Medicine Co., Ltd. · Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP), Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP)

  • HSK31679Phase 32 trials

    Haisco Pharmaceutical Group Co., Ltd. · MASH - Metabolic Dysfunction-Associated Steatohepatitis, NASH (Non-Alcoholic Steatohepatitis), Non-Alcoholic Steatohepatitis (NASH)

  • Human Diploid CellInactivated Hepatitis A Vaccine, HealivePhase 32 trials

    Sinovac Biotech Co., Ltd · Hepatitis A Vaccine, Rabies Prevention

  • ibuzatrelvirPF-07817883Phase 32 trials

    Pfizer · COVID-19 SARS-CoV-2 Infection, COVID-19 Infection

  • IIV-HDstandalonePhase 32 trials

    Sanofi · COVID-19 Immunization, Influenza Immunization, Immunization

  • LG Chem · Diphtheria, Tetanus, Pertussis

  • MG1111BARICELA, Barycela inj.Phase 32 trials

    Green Cross Corporation · Varicella, Varicella (Chickenpox), Chickenpox Vaccine

  • MTBVACBBV169Phase 32 trials

    Biofabri, S.L · Tuberculosis, Tuberculosis (TB)

  • nacubactamPhase 32 trials

    Meiji Seika Pharma Co., Ltd. · Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia

  • OBRPhase 32 trials

    Gilead Sciences · HIV-1-infection

  • OlorofimF901318Phase 32 trials

    F2G Ltd · Coccidioidomycosis, Disseminated Fungal Infection, Coccidioides Infection

  • PTM FPhase 32 trials

    Gilead Sciences · Pre-Exposure Prophylaxis of HIV Infection

  • PTM LENPhase 32 trials

    Gilead Sciences · Pre-Exposure Prophylaxis of HIV Infection

  • RSVPreF3 OA vaccinePhase 32 trials

    GSK · Respiratory Syncytial Virus Infections

  • RVX000222apabetalone, RVX-208Phase 32 trials

    Resverlogix Corp · Post-Acute COVID-19 Syndrome, Kidney Failure, Chronic

  • su vaccineRZVPhase 32 trials

    GSK · Herpes Zoster, Respiratory Syncytial Virus (RSV)

  • TB-PPDPurified Protein Derivative of TuberculinPhase 32 trials

    Chengdu CoenBiotech Co., Ltd · Tuberculosis, Latent Tuberculosis Infection

  • TDFPhase 32 trials

    Merck & Co. · Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis, Chronic Hepatitis B Infection

  • TestofenPhase 32 trials

    RDC Clinical Pty Ltd · Long Covid19, Erectile Dysfunction

  • TMPSMX, Trimethoprim-sulfamethoxazolePhase 32 trials

    Locus Biosciences · Urinary Tract Infections, Candidemia, Mycoses

  • TNM001Phase 32 trials

    Zhuhai Trinomab Pharmaceutical Co., Ltd. · Respiratory Syncytial Virus Infections

  • VYD2311Phase 32 trials

    Invivyd, Inc. · Long COVID, COVID-19 (SARS-CoV-2 Infection), COVID 19 Vaccine

  • zelicapavirPhase 32 trials

    Enanta Pharmaceuticals, Inc · RSV, RSV Infection, Respiratory Syncytial Virus (RSV)

  • ZiresovirAK0529Phase 32 trials

    Shanghai Ark Biopharmaceutical Co., Ltd. · Respiratory Syncytial Virus Infections, Respiratory Synctial Virus Infections

  • ZSP1273Phase 32 trials

    Guangdong Raynovent Biotech Co., Ltd · Influenza A, Influenza a

  • ADC189Phase 31 trial

    Jiaxing AnDiCon Biotech Co.,Ltd · Influenza Type A, Influenza Type B

  • BK1803Phase 31 trial

    Tanabe Pharma Corporation · Pertussis, Diphtheria, Tetanus

  • BMS-663068Phase 31 trial

    GSK · HIV Infections

  • BRC-201TG-1000, Pixavir MarboxilPhase 31 trial

    Boryung Biopharma Co., Ltd. · Influenza

  • DAS181Phase 31 trial

    Ansun Biopharma, Inc. · Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised

  • DWC202301Phase 31 trial

    Daewoong Pharmaceutical Co. LTD. · Helicobacter Pylori Infection, Helicobacter Pylori Infected Patients, Helicobacter Pylori Infected Subjects

  • GC5103Undiluted .-Hepabig inj, Diluted .-Hepabig injPhase 31 trial

    GC Biopharma Corp · Hepatitis B

  • IVA337LanifibranorPhase 31 trial

    Inventiva Pharma · NASH - Nonalcoholic Steatohepatitis

  • LibevitugPhase 31 trial

    Huahui Health · Chronic Hepatitis D Infection

  • LMN-201Phase 31 trial

    Lumen Bioscience, Inc. · Clostridioides Difficile Infection

  • LYB005Phase 31 trial

    Guangzhou Patronus Biotech Co., Ltd. · Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus (RSV) Infection, RSV Vaccine

  • MolnupiravirMK-4482, LAGEVRIOPhase 31 trial

    Merck & Co. · Coronavirus Disease (COVID-19)

  • mRNA-1018-H5Phase 31 trial

    Moderna · Influenza

  • NVXC19EU licensed, standalonePhase 31 trial

    Sanofi · Immunization, Healthy Volunteers, COVID-19 Immunization

  • PCV13iPhase 31 trial

    CanSino Biologics Inc. · Pneumococcal Infections, Streptococcal Infections, Bacterial Infections

  • PLG0206Phase 31 trial

    Peptilogics · Prosthetic-joint Infection

NewerPage 2 of 6Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.